Myeloma (Canada) PSP Engagement Summary

Contents

Published: 19 July 2021

Version: 1

Print this document

Gathering uncertainties

Methods used (e.g. survey, focus groups, interviews): survey 

  Number %
Total respondents (across all methods) 594 100
Total patients  339 57
Total caregivers 73 12
Total health and care professionals 27 5
Total other 15 3
Total not specified 140 24
Total number of original uncertainties submitted 3042 100
Original uncertainties in scope 2742  90
Original uncertainties out of scope 300  10

 

Interim prioritisation

Methods used (eg survey, focus groups, interviews): survey

  Number %
Total number of indicative questions (answered & unanswered) 66 100
Number of verified answered questions 7 15
Number of verified unanswered questions 59 85
Number of verified unanswered questions included in the interim prioritisation 45  
Total respondents (across all methods) 651 100
Total patients  442 68
Total carergivers 150 23
Total health and care professionals 35 5
Total other 22 3
Total not specified 2 0
Number of questions taken to final workshop 18  

 

Final priority setting workshop

  Number %
Total participants*** 23 100
Total patients  8 35
Total caregivers 6 26
Total health and care professionals 7 30
Total caregivers/health care professionals 2 9

Notes: 

Examples of “Other:” family members of people with myeloma (who did not identify as a caregiver), people with related disorders such as MGUS (a precursor to myeloma).

In the first survey the question about role (i.e., patient, caregiver, health professional) was at the end of the survey resulting in a large proportion of missing data this was corrected for the second survey.